Comment
. 2004 Nov;10(11):1153; author reply 1153-4.
doi: 10.1038/nm1104-1153a.
Translation of cancer immunotherapies
- PMID: 15516900
- DOI: 10.1038/nm1104-1153a
Item in Clipboard
Comment
Translation of cancer immunotherapies
Nat Med.
2004 Nov.
No abstract available
Comment on
-
Cancer immunotherapy: breaking the barriers to harvest the crop.Nat Med. 2004 Sep;10(9):887-92. doi: 10.1038/nm0904-887. Nat Med. 2004. PMID: 15340404
Similar articles
-
Cancer immunotherapy: breaking the barriers to harvest the crop.Nat Med. 2004 Sep;10(9):887-92. doi: 10.1038/nm0904-887. Nat Med. 2004. PMID: 15340404
-
Translation of cancer immunotherapies.Nat Med. 2004 Nov;10(11):1154-5; author reply 1155. doi: 10.1038/nm1104-1154. Nat Med. 2004. PMID: 15516901 No abstract available.
-
Business barriers slowing the pace of cancer immunotherapy research and development.J Natl Cancer Inst. 2007 Nov 7;99(21):1570-3. doi: 10.1093/jnci/djm219. Epub 2007 Oct 30. J Natl Cancer Inst. 2007. PMID: 17971521 No abstract available.
-
New opportunities for the development of cancer immunotherapies.Cancer J Sci Am. 1998 May;4 Suppl 1:S1-4. Cancer J Sci Am. 1998. PMID: 9619263 Review. No abstract available.
-
Update on the National Cancer Institute's clinical trials cooperative group program.J Am Coll Radiol. 2004 Nov;1(11):865-6. doi: 10.1016/j.jacr.2004.07.009. J Am Coll Radiol. 2004. PMID: 17411719 Review. No abstract available.
Cited by
-
Peritoneal Dissemination and Malignant Ascites in Duodenal Cancer Successfully Treated With Adoptive Cell Therapy Using WT1- and MUC1-Pulsed Dendritic Cells and Activated T Cells With No Adverse Effects: A Case Report.Cureus. 2024 Nov 30;16(11):e74834. doi: 10.7759/cureus.74834. eCollection 2024 Nov. Cureus. 2024. PMID: 39737308 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
